[Gestational diabetes--what do we learn from the HAPO-Study?].
Schäfer-Graf
U
U
Gynäkologin und Diabetologin DDG, Berliner Diabeteszentrum für Schwangere. ute.schaefer-graf@sjk.de
D044903:Congenital Hyperinsulinism / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D016640:Diabetes, Gestational / Q000097:blood / Q000175:diagnosis* / Q000517:prevention & control; D005260:Female; D005313:Fetal Death / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D005320:Fetal Macrosomia / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D005951:Glucose Tolerance Test; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening; D008431:Maternal-Fetal Exchange / Q000502:physiology; D011247:Pregnancy; D011256:Pregnancy Outcome; D012016:Reference Values; D012307:Risk Factors